10x Genomics, Inc.
TXG
Κατάταξη σε μετοχές
#2174
Headquartered in Pleasanton, California, 10x Genomics, Inc. (founded in 2012... Headquartered in Pleasanton, California, 10x Genomics, Inc. (founded in 2012 and known as 10X Technologies, Inc. until November 2014) is a prominent life science technology company. The firm specializes in creating and distributing sophisticated instrumentation, essential consumables, and software designed for in-depth analysis of biological systems. Its market presence extends globally, covering North America, Europe, the Middle East, Africa, China, and the Asia Pacific. The company's offerings feature Chromium and Chromium Connect instruments, supported by indispensable items such as microfluidic chips, slides, and reagents. A significant portion of their portfolio focuses on single-cell solutions, leveraging their Chromium platforms. These allow for precise measurement of gene activity at the individual cell level (single cell gene expression), detailed assessment of immune cell function and their targets (single cell immune profiling), exploration of DNA's physical organization and epigenetic modifications (single cell Assay for Transposase Accessible Chromatin - ATAC), and the concurrent quantification of both genetic activity and epigenetic programming across tens of thousands of cells in a single experiment (single cell multiome ATAC + gene expression). Additionally, 10x Genomics offers the Visium spatial gene expression solution, which maps gene activity patterns within specific tissue sections and can also facilitate co-detection of gene expression and proteins when paired with immunofluorescence. Their varied customer base includes academic, governmental, biopharmaceutical, and biotechnology organizations, among others.
Τιμή μετοχής
$72.10
Τελευταίος συγχρονισμός: 2026-10-20
Κεφαλαιοποίηση
$9.39B
Αλλαγή (1 ημέρα)
3.16%
Αλλαγή (1 έτος)
453.34%
Χώρα
US
Εμπόριο 10x Genomics, Inc. (TXG)
Κατηγορία
Healthcare
Έσοδα για την 10x Genomics, Inc. (TXG)
Έσοδα τον Jun 2026 TTM: $616.91M
Σύμφωνα με τις τελευταίες οικονομικές αναφορές της 10x Genomics, Inc., τα τρέχοντα έσοδα της εταιρείας (TTM) είναι $616.91M. Το 2024, η εταιρεία είχε έσοδα $610.79M μείωση σε σύγκριση με τα έσοδα του έτους 2023, τα οποία ήταν $618.73M. Τα έσοδα είναι το συνολικό ποσό που παράγει μια εταιρεία από τις πωλήσεις προϊόντων ή υπηρεσιών. Σε αντίθεση με τα κέρδη, δεν αφαιρούνται έξοδα.
Ιστορικό εσόδων για την 10x Genomics, Inc. από 2017 έως 2026
Έσοδα στο τέλος κάθε έτους
| Έτος | Έσοδα | Αλλαγή |
|---|---|---|
| 2026 (TTM) | $616.91M | -4.03% |
| 2025 | $642.82M | 5.25% |
| 2024 | $610.79M | -1.28% |
| 2023 | $618.73M | 19.81% |
| 2022 | $516.41M | 5.28% |
| 2021 | $490.49M | 64.13% |
| 2020 | $298.85M | 21.53% |
| 2019 | $245.89M | 68.06% |
| 2018 | $146.31M | 105.83% |
| 2017 | $71.09M | 0.00% |
Έσοδα για παρόμοιες εταιρείες ή ανταγωνιστές
| Εταιρεία | Έσοδα | Διαφορά Εσόδων | Χώρα |
|---|---|---|---|
| $20.24B | 3,181.35% |
US
|
|
| $184.56M | -70.08% |
AU
|
|
| $14.37B | 2,229.61% |
US
|
|
| $1.43B | 132.13% |
US
|
|
| - | - |
US
|
